Yoshio Akagi

1.6k total citations
46 papers, 1.3k citations indexed

About

Yoshio Akagi is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, Yoshio Akagi has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 15 papers in Cell Biology and 12 papers in Physiology. Recurrent topics in Yoshio Akagi's work include Connexins and lens biology (16 papers), Aldose Reductase and Taurine (13 papers) and Biochemical effects in animals (8 papers). Yoshio Akagi is often cited by papers focused on Connexins and lens biology (16 papers), Aldose Reductase and Taurine (13 papers) and Biochemical effects in animals (8 papers). Yoshio Akagi collaborates with scholars based in Japan and United States. Yoshio Akagi's co-authors include Eri Kubo, Peter F. Kador, Dhirendra P. Singh, Nigar Fatma, Yoshihiro Takamura, Jin H. Kinoshita, Yoshihiro Takamura, Takanobu Taniguchi, Ikunobu Muramatsu and Yoshiaki Nojyo and has published in prestigious journals such as Development, Diabetes and The Journal of Comparative Neurology.

In The Last Decade

Yoshio Akagi

45 papers receiving 1.3k citations

Peers

Yoshio Akagi
J Cermák United States
Xiaoxi Qiao United States
Yang Yuan United States
I. D. Millar United Kingdom
Masako M. Bilak United States
Yoshio Akagi
Citations per year, relative to Yoshio Akagi Yoshio Akagi (= 1×) peers Laura Contreras

Countries citing papers authored by Yoshio Akagi

Since Specialization
Citations

This map shows the geographic impact of Yoshio Akagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshio Akagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshio Akagi more than expected).

Fields of papers citing papers by Yoshio Akagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshio Akagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshio Akagi. The network helps show where Yoshio Akagi may publish in the future.

Co-authorship network of co-authors of Yoshio Akagi

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshio Akagi. A scholar is included among the top collaborators of Yoshio Akagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshio Akagi. Yoshio Akagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takamura, Yoshihiro, et al.. (2009). Aldose reductase inhibitor counteracts the attenuated adhesion of human corneal epithelial cells induced by high glucose through modulation of MMP-10 expression. Diabetes Research and Clinical Practice. 86(1). 16–23. 9 indexed citations
2.
Takamura, Yoshihiro, Eri Kubo, & Yoshio Akagi. (2009). Analysis of the Effect of Intravitreal Bevacizumab Injection on Diabetic Macular Edema after Cataract Surgery. Ophthalmology. 116(6). 1151–1157. 69 indexed citations
3.
Kubo, Eri, et al.. (2008). Attenuation of aldose reductase gene suppresses high-glucose-induced apoptosis and oxidative stress in rat lens epithelial cells. Diabetes Research and Clinical Practice. 82(1). 18–24. 19 indexed citations
4.
Kador, Peter F., et al.. (2007). Age-Dependent Retinal Capillary Pericyte Degeneration in Galactose-Fed Dogs. Journal of Ocular Pharmacology and Therapeutics. 23(1). 63–69. 12 indexed citations
5.
Takamura, Yoshihiro, et al.. (2007). Epithelial cell density in cataractous lenses of patients with diabetes: Association with erythrocyte aldose reductase. Experimental Eye Research. 85(3). 393–399. 17 indexed citations
6.
Toris, Carol B., James T. Lane, Yoshio Akagi, Karen Blessing, & Peter F. Kador. (2006). Aqueous flow in galactose-fed dogs. Experimental Eye Research. 83(4). 865–870. 4 indexed citations
7.
Taniguchi, Takanobu, et al.. (2005). Characteristics of acid extrusion from Chinese hamster ovary cells expressing different prostaglandin EP receptors. Life Sciences. 78(21). 2454–2462. 5 indexed citations
8.
Fatma, Nigar, Eri Kubo, Leo T. Chylack, et al.. (2004). LEDGF regulation of alcohol and aldehyde dehydrogenases in lens epithelial cells: stimulation of retinoic acid production and protection from ethanol toxicity. American Journal of Physiology-Cell Physiology. 287(2). C508–C516. 22 indexed citations
9.
Yagi, Hideshi, Yoshihiro Takamura, Takunari Yoneda, et al.. (2004). Vlgr1 knockout mice show audiogenic seizure susceptibility. Journal of Neurochemistry. 92(1). 191–202. 48 indexed citations
10.
Taniguchi, Takanobu, et al.. (2002). Two-phase response of acid extrusion triggered by purinoceptor in Chinese hamster ovary cells. European Journal of Pharmacology. 455(1). 19–25. 9 indexed citations
11.
Takamura, Yoshihiro, et al.. (2002). Increased Expression of p21WAF-1/CIP-1 in the Lens Epithelium of Rat Sugar Cataract. Experimental Eye Research. 74(2). 245–254. 8 indexed citations
12.
Suzuki, Fumiko, Takanobu Taniguchi, Seigo Nakamura, et al.. (2002). Distribution of alpha‐1 adrenoceptor subtypes in RNA and protein in rabbit eyes. British Journal of Pharmacology. 135(3). 600–608. 54 indexed citations
13.
Takamura, Yoshihiro, Hideshi Yagi, Takunari Yoneda, et al.. (2001). JDD1, a Novel Member of the DnaJ Family, Is Expressed in the Germinal Zone of the Rat Brain. Biochemical and Biophysical Research Communications. 285(2). 387–392. 4 indexed citations
14.
Kubo, Eri, et al.. (1999). Inhibitory effect of orally administered aldose reductase inhibitor SNK-860 on corneal polyol accumulation in galactose-fed rats. Graefe s Archive for Clinical and Experimental Ophthalmology. 237(9). 758–762. 5 indexed citations
15.
Nakamura, Seigo, Takanobu Taniguchi, Fumiko Suzuki, Yoshio Akagi, & Ikunobu Muramatsu. (1999). Evaluation of α1‐adrenoceptors in the rabbit iris: pharmacological characterization and expression of mRNA. British Journal of Pharmacology. 127(6). 1367–1374. 43 indexed citations
16.
Kubo, Eri, Kazuhiko Mori, Yukio Takahashi, et al.. (1998). Effect of Aldose Reductase Inhibitor on Corneal Epithelial Barrier Function in Galactose-Fed Dogs. Journal of Ocular Pharmacology and Therapeutics. 14(2). 181–190. 3 indexed citations
17.
Okamura, Hitoshi, et al.. (1992). Localization of vasoactive intestinal peptide (VIP) messenger RNA (mRNA) in amacrine cells of rat retina. Current Eye Research. 11(7). 711–715. 10 indexed citations
18.
Okamura, Hitoshi, et al.. (1990). Contrary effect of eye enucleation on VIP-immunoreactive neurons in the suprachiasmatic nucleus and the superior colliculus of the rat. Neuroscience Letters. 112(2-3). 137–142. 30 indexed citations
19.
Akagi, Yoshio & Peter F. Kador. (1990). Effect of aldose reductase inhibitors on the progression of retinopathy in galactose-fed dogs. Experimental Eye Research. 50(6). 635–639. 15 indexed citations
20.
Akagi, Yoshio, Motokazu Itoi, & Yutaka Sano. (1980). Monoamine-Containing Neurons in the Retina of Monkey. Japanese Journal of Ophthalmology. 24(4). 428–438. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026